2007
DOI: 10.1590/s1980-57642008dn10200002
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the gastrin-releasing peptide receptor pathway to treat cognitive dysfunction associated with Alzheimer's Disease

Abstract: Increasing evidence indicates that bombesin (BB)-like peptides (BLPs), such as the gastrin-releasing peptide (GRP) and its receptor (GRPR), might play a role in neurological and psychiatric disorders. The present study reviews findings from animal and human studies suggesting that the GRPR should be considered a target for the treatment of cognitive dysfunction in patients with Alzheimer’s disease (AD). Abnormalities in GRPR-triggered signaling have been described in both fibroblasts from patients with AD, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…When DHA reaches the lumen of the GI tract and/or the hippocampus, it is likely to induce GRP–GRPR activity and hence might affect GI tract and hippocampus functions. GRP and GRPR binding might activate PKC or PKA and affect their downstream signaling [ 45 ] in neurons.…”
Section: Discussionmentioning
confidence: 99%
“…When DHA reaches the lumen of the GI tract and/or the hippocampus, it is likely to induce GRP–GRPR activity and hence might affect GI tract and hippocampus functions. GRP and GRPR binding might activate PKC or PKA and affect their downstream signaling [ 45 ] in neurons.…”
Section: Discussionmentioning
confidence: 99%
“…Since the bombesin receptor subtype 3, the mammalian ortholog of CCHa2-R, is also implicated in memory consolidation ( Flood and Morley, 1988 ; Shumyatsky et al, 2002 ; Roesler et al, 2004 ; Ghanbari et al, 2018 ; Melzer et al, 2021 ), our findings may further reinforce the evolutionarily conserved function of the CCHa2 system. Moreover, it is noteworthy that the bombesin receptor is involved in the etiology of Alzheimer’s disease ( Roesler et al, 2007 ). The notion is supported by the abnormal receptor signaling observed in the patient’s fibroblasts and a transgenic mouse model of Alzheimer’s disease ( Ito et al, 1994 ; Huang et al, 2005 ).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, decades of research critically conjoined the bombesin receptor function in memory consolidation ( Flood and Morley, 1988 ; Shumyatsky et al, 2002 ; Roesler et al, 2004 ; Ghanbari et al, 2018 ; Melzer et al, 2021 ). Abnormalities in the bombesin receptor pathway in patients with Alzheimer’s disease ( Roesler et al, 2007 ) suggest an as-yet-unsolved cognitive feature of the metabolic neuropeptide family. However, any attributes that signify CCHa2’s function in the cognitive process are so far unclear.…”
Section: Introductionmentioning
confidence: 99%